Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Ketoconazole and RU-58841 Interaction: Compatible | Peptide Database

Compound Profiles Ketoconazole Antifungal | Topical Anti-Androgen for Hair Loss Ketoconazole works through multiple pathways relevant to hair loss. As an azole antifungal, it inhibits the enzyme lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Ketoconazole

Antifungal | Topical Anti-Androgen for Hair Loss

Ketoconazole works through multiple pathways relevant to hair loss. As an azole antifungal, it inhibits the enzyme lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis and killing Malassezia fungi that colonize the scalp and contribute to inflammation and seborrheic dermatitis.

RU-58841

Topical Anti-Androgen | Experimental Hair Loss Treatment

RU-58841 functions as a competitive antagonist of the androgen receptor (AR). When applied topically to the scalp, it penetrates the skin and binds directly to androgen receptors in dermal papilla cells of hair follicles, preventing dihydrotestosterone (DHT) and testosterone from activating those receptors.

Combined Organ Load

Frequently Asked Questions

Can I take Ketoconazole with RU-58841?

Yes, Ketoconazole and RU-58841 can generally be taken together. Both act topically but through different mechanisms. RU-58841 is a non-steroidal androgen receptor antagonist, while ketoconazole disrupts DHT binding and reduces fungal-driven inflammation. No known negative interactions when used together.

Is Ketoconazole and RU-58841 safe together?

Based on documented research, this combination is considered compatible. No critical safety flags identified for this pair.

What are the interactions between Ketoconazole and RU-58841?

Both act topically but through different mechanisms. RU-58841 is a non-steroidal androgen receptor antagonist, while ketoconazole disrupts DHT binding and reduces fungal-driven inflammation. No known negative interactions when used together. This assessment has 90% confidence and is based on documented research data.

How should I time Ketoconazole and RU-58841?

Ketoconazole has a half-life of Topical application stays local with minimal systemic absorption and RU-58841 has a half-life of ~1 hour topically (very short systemic half-life). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Protects blood vessels from age-related deterioration through gene expression regulation. Limits development of atherosclerotic plaques in blood vessels. Decreases endothelial dysfunction that contributes to cardiovascular disease. Regulates sirtuin 1 levels, mimicking some benefits of calorie restriction. Enhances mesenchymal stem cell proliferation and reduces senescence. Reverses senescence-associated secretory phenotype in aging cells.

Source: peptide-db.com ↗

Research Indications

The 2019 Isenmann et al. study at Freie Universitat Berlin demonstrated that ecdysterone supplementation (administered as spinach extract standardized to ecdysterone content) produced significantly greater increases in lean muscle mass compared to placebo over 10 weeks of resistance training in young, trained men. The highest-dose group gained approximately 2 kg more lean mass than placebo. These results, combined with earlier Soviet-era research and multiple animal studies, support ecdysterone as a meaningful natural anabolic agent. Participants in the Berlin study also showed greater improvements in one-repetition maximum bench press compared to placebo. Animal studies have demonstrated improved grip strength, endurance capacity, and force production with ecdysterone administration. The mechanism likely involves both increased muscle protein synthesis and improved calcium handling within muscle fibers, enhancing contractile efficiency. Preclinical evidence suggests ecdysterone accelerates recovery from exercise-induced muscle damage through anti-inflammatory effects and enhanced protein synthesis rates. Users frequently report reduced delayed-onset muscle soreness (DOMS) and improved training frequency tolerance. However, dedicated human recovery studies are limited. By promoting lean mass accretion without androgenic hormonal disruption, ecdysterone may support body recomposition (simultaneous fat loss and muscle gain) particularly in trained individuals on a structured nutrition plan. Some animal data suggest mild lipolytic effects, though this has not been convincingly demonstrated in human trials.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Subcutaneous injection is the primary administration route. Best administered on an empty stomach for optimal GH release. Multiple daily doses recommended to maintain elevated GH levels. GH optimization 100-150 mcg 2-3x daily SubQ Enhanced results 200-300 mcg With GHRH (synergy) 100 mcg each SubQ (combined) Pre-sleep protocol 100-200 mcg Before bed

Source: peptide-db.com ↗
Potential benefits

How long before noopept's memory benefits become noticeable?

Acute mental clarity effects appear within 15-30 minutes of sublingual administration or 1-2 hours if swallowed. However, the deeper memory and neuroprotective benefits from BDNF/NGF upregulation take 1-2 weeks of daily use to manifest. Most users report that the true value of noopept becomes apparent after 4-8 weeks of consistent cycling, with memory improvements that outlast the supplementation period.

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides